ROCHESTER MEDICAL CORPORATION (ROCM) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 391 transactions totaling $17.0M, demonstrating a bearish sentiment with -$16.7M in net insider flow. The most recent transaction on Nov 14, 2013 involved a transaction of 21,157 shares valued at $423.1K.
No significant insider buying has been recorded for ROCM in the recent period.
No significant insider selling has been recorded for ROCM in the recent period.
Based on recent SEC filings, insider sentiment for ROCM is bearish with an Insider Alignment Score of 1/100 and a net flow of -$16.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at ROCHESTER MEDICAL CORPORATION (ROCM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading ROCM stock, having executed 391 transactions in the past 90 days. The most active insider is Anthony J. Conway (Executive), who has made 64 transactions totaling $23.5M.
Get notified when executives and directors at ROCM file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 14, 2013 | M. Anglin Robert | Executive | Disposition | 21,157 | $20.00 | $423.1K | |
| Nov 14, 2013 | M. Anglin Robert | Executive | Award | 10,557 | $N/A | $0 | |
| Nov 14, 2013 | L. Boehm Darnell | Executive | Disposition | 24,642 | $20.00 | $492.8K | |
| Nov 14, 2013 | M. Carper James | Executive | Disposition | 14,389 | $20.00 | $287.8K | |
| Nov 14, 2013 | M. Carper James | Executive | Award | 13,889 | $N/A | $0 | |
| Nov 14, 2013 | J. Conway Anthony | Executive | Award | 33,115 | $N/A | $0 | |
| Nov 14, 2013 | J. Conway Anthony | Executive | Disposition | 63,755 | $20.00 | $1.3M | Large |
| Nov 14, 2013 | J. Conway Anthony | Executive | Disposition | 839,519 | $20.00 | $16.8M | Large |
| Nov 14, 2013 | J. Conway Philip | Executive | Disposition | 409,506 | $20.00 | $8.2M | Large |
| Nov 14, 2013 | J. Conway Philip | Executive | Disposition | 9,600 | $20.00 | $192.0K | |
| Nov 14, 2013 | J. Conway Philip | Executive | Award | 15,363 | $N/A | $0 | |
| Nov 14, 2013 | L. Grinde Sarah | Executive | Disposition | 21,699 | $20.00 | $434.0K | |
| Nov 14, 2013 | L. Grinde Sarah | Executive | Award | 8,476 | $N/A | $0 | |
| Nov 14, 2013 | A. Jonas David | Executive | Disposition | 110,711 | $20.00 | $2.2M | Large |
| Nov 14, 2013 | A. Jonas David | Executive | Award | 18,211 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Disposition(D) | 13 | $32.1M | 59.7% |
Sale(S) | 243 | $16.8M | 31.3% |
Exercise(M) | 89 | $4.2M | 7.7% |
Payment(F) | 3 | $485.7K | 0.9% |
Purchase(P) | 23 | $168.7K | 0.3% |
Award(A) | 19 | $0 | 0.0% |
Will Acquisition(W) | 1 | $0 | 0.0% |
Insider selling pressure at ROCHESTER MEDICAL CORPORATION has increased, with 14 insiders executing 391 transactions across all time. Total sales of $16.8M significantly outpace purchases of $168.7K, resulting in a net outflow of $16.7M. This selling activity appears largely discretionary, which may warrant closer attention from investors.